US Patent Issued to Regeneron Pharmaceuticals on June 30 for "Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof" (New York Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,632, issued on June 30, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof" was invented by Andrew J. Murphy (Croton-on-Hudson, N.Y.), Dimitris Skokos (New York), Janelle Waite (Bronx, N.Y.), Erica Ullman (Yorktown Heights, N.Y.), Aynur Hermann (New York), Eric Smith (New York), Lauric Haber (Rye Brook, N.Y.), George D. Yancopoulos (Yorktown Heights, N.Y.) and Alison Crawford (Dobbs Ferry, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides bispecific antigen-binding molecules comprising a first antigen-binding domain that specifically binds ...